For the fourth consecutive year, The RAM participated in the Ales for ALS fundraising campaign, and brewed a unique beer to raise money for the cause. One dollar from each pint of their IPA 4 ALS sold during the month of August was donated to the ALS Therapy Development Institute, the world’s leader in ALS research. At the Grand Ridge Plaza restaurant, beer lovers enjoyed 1038 pints, which was the fourth highest amount among all RAM locations.
The Ales for ALS program was created by Loftus Ranches and Hopunion in Yakima, WA. It provides a promising and experimental one-of-a-kind hop pellet blend to a select handful of brewers throughout the U.S. to create their own special brew. Since the program’s inception in 2013, participating breweries have collectively raised more than $1.25 million for ALS research.
The RAM tapped its 2017 IPA 4 ALS small batch seasonal release at all locations, with copious fresh, cold pints enjoyed at the Grand Ridge Plaza restaurant. Their IPA 4 ALS hops blend featured citra, loral and four experimental varieties.
According to The RAM’s Director of Brewery Operations, David Leonard, the aromatic hops produced “dank tropical fruit with pungent citrus notes” that had equal appeal for beer lovers and hops aficionados.
Cheers to all who enjoyed a pint for the cause!
About ALS Therapy Development Institute
The ALS Therapy Development Institute (ALS TDI) and its scientists actively discover and develop treatments for ALS. It is the world’s first and largest nonprofit biotech focused 100 percent on ALS research.
What is ALS?
Amyotrophic lateral sclerosis (known as ALS or Lou Gehrig’s disease) is a progressive neurodegenerative disease that leads to paralysis, due to the death of motor neurons in the spinal cord and brain.
- There is no known cure for the disease.
- The average person survives only 2 to 5 years following diagnosis.
- About 5,000 people in the U.S. are diagnosed with ALS each year.
- There are about 30,000 people in the U.S. diagnosed with ALS today.
- The worldwide population of ALS patients is estimated at 450,000.